INGREZZA

Neurocrine Biosciences, Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 17, 2026
Approval ID: 4c970164-cafb-421f-9eb5-c226ef0a3417
Products: 5 registered
Version: 34

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INGREZZA or INGREZZA SPRINKLE safely and effectively. See full prescribing information for INGREZZA. INGREZZA (valbenazine) capsules, for oral use INGREZZA SPRINKLE (valbenazine) capsules, for oral use Initial U.S. Approval: 2017

Quick Stats

Total Products5

Labelers2

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.